ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.78725
-0.05%
Brent Oil
84.295
-0.04%
Bitcoin
68,436.64
0.21%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Sophiris Bio Inc (SPHS)

  7. Sophiris Bio Inc (SPHS) Noticias

SPHS

Sophiris Bio (SPHS)

Sophiris Bio Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SPHS
FechaHoraFuenteTítuloSímboloCompañía
11/03/202015:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SPHSSophiris Bio Inc
14/02/202013:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SPHSSophiris Bio Inc
23/12/201915:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SPHSSophiris Bio Inc
13/11/201905:01Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:SPHSSophiris Bio Inc
08/11/201915:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SPHSSophiris Bio Inc
21/10/201907:00PR Newswire (US)Sophiris Bio Receives Positive Feedback from FDA Regarding Phase 3 Localized Prostate Cancer Clinical Trial DesignNASDAQ:SPHSSophiris Bio Inc
08/10/201915:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SPHSSophiris Bio Inc
06/09/201916:22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SPHSSophiris Bio Inc
06/09/201914:03Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SPHSSophiris Bio Inc
30/08/201907:00PR Newswire (US)Sophiris Bio Announces Completion of $4.0 Million Registered Direct OfferingNASDAQ:SPHSSophiris Bio Inc
30/08/201907:00PR Newswire (US)Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceNASDAQ:SPHSSophiris Bio Inc
28/08/201905:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SPHSSophiris Bio Inc
27/08/201907:12PR Newswire (US)Sophiris Bio Announces $4.0 Million Registered Direct OfferingNASDAQ:SPHSSophiris Bio Inc
19/06/201907:30PR Newswire (US)Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical T...NASDAQ:SPHSSophiris Bio Inc
09/05/201915:05PR Newswire (US)Sophiris Bio Reports First Quarter 2019 Financial ResultsNASDAQ:SPHSSophiris Bio Inc
30/04/201915:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SPHSSophiris Bio Inc
30/04/201915:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SPHSSophiris Bio Inc
02/04/201915:05PR Newswire (US)Sophiris Bio to Present at Two Upcoming Investor ConferencesNASDAQ:SPHSSophiris Bio Inc
13/03/201916:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SPHSSophiris Bio Inc
13/03/201915:05PR Newswire (US)Sophiris Bio Reports Fourth Quarter 2018 and Year-end Financial Results and Recent Corporate HighlightsNASDAQ:SPHSSophiris Bio Inc
21/12/201815:51Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SPHSSophiris Bio Inc
17/12/201807:00PR Newswire (US)Sophiris Bio Provides Updates on Phase 2b Localized Prostate Cancer TrialNASDAQ:SPHSSophiris Bio Inc
15/11/201815:05PR Newswire (US)Sophiris Bio to Present at the Piper Jaffray Healthcare ConferenceNASDAQ:SPHSSophiris Bio Inc
13/11/201815:05PR Newswire (US)Sophiris Bio Reports Third Quarter 2018 Financial Results and Recent Corporate HighlightsNASDAQ:SPHSSophiris Bio Inc
25/09/201807:00PR Newswire (US)Sophiris Bio to Present at the Cantor Global Healthcare ConferenceNASDAQ:SPHSSophiris Bio Inc
20/09/201812:33Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SPHSSophiris Bio Inc
14/09/201807:00PR Newswire (US)Sophiris Bio Extends the Interest Only Period under its Loan and Security AgreementNASDAQ:SPHSSophiris Bio Inc
29/08/201815:30PR Newswire (US)Sophiris Bio to Present at the H.C. Wainwright 20th Annual Global Investment ConferenceNASDAQ:SPHSSophiris Bio Inc
29/08/201807:00PR Newswire (US)Sophiris Bio Updates on Phase 2b Localized Prostate Cancer TrialNASDAQ:SPHSSophiris Bio Inc
14/08/201815:05PR Newswire (US)Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate HighlightsNASDAQ:SPHSSophiris Bio Inc
 Showing the most relevant articles for your search:NASDAQ:SPHS

Su Consulta Reciente

AMEX
XLF
Financial Select Sector
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
NASDAQ
AMZN
Amazon.com
FX
EURMXN
Euro vs MXN
COIN
BTCUSD
Bitcoin
NYSE
VZ
Verizon Communications
USOTC
BNPQY
BNP Paribas (QX)
USOTC
RHHBY
Roche (QX)
NASDAQ
AAPL
Apple
NYSE
BAC
Bank of America
USOTC
BASFY
BASF (QX)
PM
XAUUSD
Gold vs US Dollar
AMEX
XLV
Health Care Select Sector
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados